Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ASCO GI 2021 | Gender representation in authorship in later-phase clinical trials in BTC

Rachna T. Shroff, MD, University of Arizona Cancer Center, Tucson, AZ, discusses the results of a study aiming to describe and assess factors associated with female first and senior authorship in later phase systemic clinical trials in biliary tract cancer (BTC). The findings suggest that female author representation in later phase systemic clinical trial publications in BTC is low and has not changed significantly over time, and that underlying reasons for this imbalance should be explored. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).